What drugs should you avoid taking with anamorelin?

Anamorelin (Anamorelin) is a drug used to treat cachexia symptoms in patients with malignant tumors. When using anamorelin, patients need to be careful to avoid concurrent use with certain medications to prevent possible drug interactions or adverse reactions.

Receptor agonists such as biguanides and ranitidine. Anamorelin itself increases gastric motility and appetite and may increase the incidence of adverse gastrointestinal effects such as nausea, vomiting, or bloating when used concomitantly with these receptor agonists. Therefore, when these drugs are used together, patients need to be closely monitored for adverse reactions and dosage adjustments or other measures taken as needed.

Anticoagulant drugs such as warfarin. Patients taking anamorelin may also need to receive anticoagulant therapy. However, use of anamorelin may increase the risk of bleeding, especially in patients with other risk factors for bleeding. Therefore, when anticoagulant drugs are used simultaneously, bleeding indicators should be monitored and dosage adjustments should be made as necessary.

In addition to the above-mentioned drugs, although there is currently no clear scientific research proving the direct interaction between anamorelin and other drugs, considering the complexity of drug metabolism and pharmacodynamics, if patients need to take other drugs, especially prescription drugs, while taking anamorelin, it is best to consult a doctor or pharmacist first.

It is contraindicated in patients allergic to anamoline hydrochloride or any of its components to avoid possible allergic reactions. It is contraindicated in patients with severe heart, liver, or kidney disease because the safety and effectiveness of the drug in these conditions have not been established. It is contraindicated in pregnant and lactating patients as there are limited data on the safety and effectiveness of anamulin in these populations.